Resources & Instructions
-
White papers May 26, 2026
Biorelevant ocular cell culture on full-length Biolaminin substrates
This white paper highlights published data on retinal pigment epithelial cells, corneal epithelial and endothelial cells, and photoreceptor progenit […]
-
Posters May 13, 2026
Substrates are a crucial part in securing PSC-derived cell therapy development and manufacturing across the production workflow
Learn how Biolaminin® 521 supports seamless and scalable PSC-derived cell therapy manufacturing across the entire production workflow.
-
Posters May 13, 2026
Biolaminin® 521, a cost-efficient and biorelevant substrate for xeno-free and clinical-compatible mesenchymal stromal cells
Learn how Biolaminin® 521 supports a complete, xeno-free and clinically compatible MSC workflow—from isolation and expansion to reprogramming and differentiation.
-
Instructions and guides April 14, 2026
Transfer from: LN521 to MX521 or CT521
This guide outlines how to transfer PSC cultures from LN521 to MX521 or CT521 with minimal changes to existing workflows. It provides […]
-
Webinars February 12, 2026
Webinar: From stem cells to neurons: advancing Parkinson’s research toward therapies
The keynote speaker, Dr. Mark Denham from Aarhus University Hospital will share how his team genetically modified human pluripotent stem cells to […]
-
Application overviews January 20, 2026
Biorelevant Differentiation of Ocular Cell Types on Biolaminin® Substrates
Explore how Biolaminin substrates provide defined, animal origin-free conditions that accelerate ocular cell differentiation and increase lineage-sp […]
-
Instructions and guides December 10, 2025
Biosilk and Biolaminin® 3D microfiber networks
Biosilk is a fully defined recombinant material that self-assembles into microfiber scaffolds for stable and reproducible 3D culture. When combined […]
-
Application overviews December 10, 2025
Long-term and tissue-specific organoids
Biosilk is an innovative recombinant silk protein offering multiple advantages over tissue-extract alternatives. It is engineered to form a robust, […]
-
Instructions and guides December 9, 2025
Guidelines for functionalization of hydrogels
This guideline describes how to functionalize hydrogels with full-length Biolaminin to create biomimetic 3D environments that support cell adhesion, […]
-
Infographics December 4, 2025
Biosilk, customizable 3D material for in vitro models
Biosilk is a recombinant 3D microfiber network that mimics the structure and mechanics of natural extracellular matrix, enabling accurate, reproduci […]
-
Application notes October 23, 2025
Improving automated cell culture
Automation in cell therapy manufacturing demands consistency and scalability. Biolaminin® 521, a full-length human recombinant laminin, enables eff […]
-
Application notes June 25, 2025
Modelling the kidney in 2D and 3D
Full-length Biolaminin® 521 and 511 enhance kidney disease models by supporting PSC-derived organoids, barrier integrity, and integration into kidney-on-a-chip platforms.